Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic, Abbott Settle Longstanding Stent IP Battles For $400 Mil.

This article was originally published in The Gray Sheet

Executive Summary

Medtronic will pay Abbott Laboratories $400 million to resolve a costly series of global stent patent battles that have dragged on since the '90s and in some cases limited the companies' ability to commercialize in certain markets

You may also be interested in...



Boston Scientific Settles More Stent Patent Suits With J&J, For $1.7 Billion

The stent patent disarmament trend continued last week with the biggest settlement yet: Boston Scientific agreed Feb. 1 to pay Johnson & Johnson/Cordis $1.725 billion to settle three disputes dating back to 2003

Boston Scientific Settles More Stent Patent Suits With J&J, For $1.7 Billion

The stent patent disarmament trend continued last week with the biggest settlement yet: Boston Scientific agreed Feb. 1 to pay Johnson & Johnson/Cordis $1.725 billion to settle three disputes dating back to 2003

Boston Scientific Settles 14 Stent Patent Suits With J&J For $716 Million

Long-time stent rivals Boston Scientific and Johnson & Johnson signed a partial patent détente Sept. 29, but the companies are not finished battling over intellectual property for the profitable devices

Related Content

Topics

UsernamePublicRestriction

Register

MT027745

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel